Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service Autores: Puig, L; Notario, J; Jimenez-Morales, A; Moreno-Ramirez, D; Lopez-Ferrer, A; Gozalbo, I; Prades, M; Lizan, L; Blanch, C Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy Autores: Rios-Tamayo, R; Martin-Garcia, A; Alarcon-Payer, C; Sanchez-Rodriguez, D; de la Guardia, AMDVD; Collado, CGG; Morales, AJ; Chacon, MJ; Barrera, JC Impact of pharmaceutical care on cardiovascular risk among older HIV patients on antiretroviral therapy Autores: Domingues, EAM; Ferrit-Martin, M; Calleja-Hernandez, MA Negative symptoms across psychotic spectrum disorders Autores: Munoz-Negro, JE; Lozano, V; Ibanez-Casas, I; de la Cruz, BG; Solere, A; Alcala, JA; Ontiveros, C; Aznarte, P; Cervilla, JA Relevance of BRAF and NRAS mutations in the primary tumor and metastases of papillary thyroid carcinomas Autores: Canadas-Garre, M; Becerra-Massare, P; Casares, AM; Calleja-Hernandez, MA; Llamas-Elvira, JM Gene polymorphisms as predictors of response to biological therapies in psoriasis patients Autores: Linares-Pineda, TM; Canadas-Garre, M; Sanchez-Pozo, A; Calleja-Hernandez, MA Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis Autores: Maldonado-Montoro, M; Canadas-Garre, M; Gonzalez-Utrilla, A; Plaza-Plaza, JC; Calleja-Hernandez, MA < 1 2 … 1.050 1.051 1.052 … 1.504 1.505 >
